ArticleNPJ digital medicine2023
A generalizable deep learning regression model for automated glaucoma screening from fundus images.
Article in NPJ digital medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- AUBADE-syn: a novel deep learning ensemble method for glaucoma detection using synthetic fundus images on imbalanced datasets.NPJ digital medicine · 2026Article
- Deep Learning-Based Generation of Retinal Nerve Fibre Layer Thickness Maps from Fundus Photographs: A Comparative Analysis of U-Net Architectures for Accessible Glaucoma Assessment.Life (Basel, Switzerland) · 2026Article
- Transformer-Based Deep Learning for Population-Scale Retinal Image Screening of Ophthalmic Disorders.Bioengineering (Basel, Switzerland) · 2026Article
- Multimodal Deep Learning Differentiates Papilledema and Non-Arteritic Anterior Ischemic Optic Neuropathy From Healthy Eyes.Investigative ophthalmology & visual science · 2026Article
- A Deep Learning Model Detects Glaucoma Based on an OCT Report, but Where Should the Clinician Look to Identify Glaucomatous Damage?Translational vision science & technology · 2025Article
- Multimodal foundation model and benchmark for comprehensive retinal OCT image analysis.NPJ digital medicine · 2025Article
- Forecasting trends in glaucoma medication reimbursees in Finland: updated system dynamics model to 2070.BMJ open ophthalmology · 2025Article
- ODDM: Integration of SMOTE Tomek with Deep Learning on Imbalanced Color Fundus Images for Classification of Several Ocular Diseases.Journal of imaging · 2025Article
- Detecting Glaucoma in Highly Myopic Eyes From Fundus Photographs Using Deep Convolutional Neural Networks.Clinical & experimental ophthalmology · 2025Article
- Artificial Intelligence in Glaucoma: Advances in Diagnosis, Progression Forecasting, and Surgical Outcome Prediction.International journal of molecular sciences · 2025Review
- A hybrid multi model artificial intelligence approach for glaucoma screening using fundus images.NPJ digital medicine · 2025Article
- Deep Learning in Glaucoma Detection and Progression Prediction: A Systematic Review and Meta-Analysis.Biomedicines · 2025Review
- Artificial intelligence technology in ophthalmology public health: current applications and future directions.Frontiers in cell and developmental biology · 2025Review
- Deep learning for predicting circular retinal nerve fiber layer thickness from fundus photographs and diagnosing glaucoma.Heliyon · 2024Article
- Generalizability of Deep Neural Networks for Vertical Cup-to-Disc Ratio Estimation in Ultra-Widefield and Smartphone-Based Fundus Images.Translational vision science & technology · 2024Article
- Computational methods in glaucoma research: Current status and future outlook.Molecular aspects of medicine · 2023Review
- [Awareness for glaucoma in the general population].Die Ophthalmologie · 2023Review
- Glaucoma Detection and Feature Identification via GPT-4V Fundus Image Analysis.Ophthalmology scienceArticle
- Highly Accurate and Precise Automated Cup-to-Disc Ratio Quantification for Glaucoma Screening.Ophthalmology scienceArticle
- Application of artificial intelligence in glaucoma care: An updated review.Taiwan journal of ophthalmologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A plethora of classification models for the detection of glaucoma from fundus images have been proposed in recent years. Often trained with data from a single glaucoma clinic, they report impressive performance on internal test sets, but tend to struggle in generalizing to external sets. This performance drop can be attributed to data shifts in glaucoma prevalence, fundus camera, and the definition of glaucoma ground truth. In this study, we confirm that a previously described regression network for glaucoma referral (G-RISK) obtains excellent results in a variety of challenging settings. Thirteen different data sources of labeled fundus images were utilized. The data sources include two large population cohorts (Australian Blue Mountains Eye Study, BMES and German Gutenberg Health Study, GHS) and 11 publicly available datasets (AIROGS, ORIGA, REFUGE1, LAG, ODIR, REFUGE2, GAMMA, RIM-ONEr3, RIM-ONE DL, ACRIMA, PAPILA). To minimize data shifts in input data, a standardized image processing strategy was developed to obtain 30° disc-centered images from the original data. A total of 149,455 images were included for model testing. Area under the receiver operating characteristic curve (AUC) for BMES and GHS population cohorts were at 0.976 [95% CI: 0.967-0.986] and 0.984 [95% CI: 0.980-0.991] on participant level, respectively. At a fixed specificity of 95%, sensitivities were at 87.3% and 90.3%, respectively, surpassing the minimum criteria of 85% sensitivity recommended by Prevent Blindness America. AUC values on the eleven publicly available data sets ranged from 0.854 to 0.988. These results confirm the excellent generalizability of a glaucoma risk regression model trained with homogeneous data from a single tertiary referral center. Further validation using prospective cohort studies is warranted.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.